| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967002 | Vaccine | 2013 | 8 Pages |
Abstract
⺠HPV prevalence (54%), incidence (45%) and persistence (34%) is high. ⺠Risk factors for HPV persistent and incident infections are different. ⺠There is an age-dependent increase within this age range for persistent infections but not for incident infections. ⺠Knowledge on type-specific HPV infections pre-vaccination is essential for monitoring the HPV vaccine.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
M. Mollers, J. Boot Hein, J. Vriend Henrike, J. King Audrey, V.F. van den Broek Ingrid, E.A.M. van Bergen Jan, A.T.P. Brink Antoinette, F.G. Wolffs Petra, J.P.A. Hoebe Christian, J.L.M. Meijer Chris, A.B. van der Sande Marianne, E. de Melker Hester,